Abstract | Despite an extensive body of reported information about peripheral and central mechanisms involved in the pathophysiology of IBS symptoms, no comprehensive disease model has emerged that would guide the development of novel, effective therapies. In this Review, we will first describe novel insights into some key components of brain-gut interactions, starting with the emerging findings of distinct functional and structural brain signatures of IBS. We will then point out emerging correlations between these brain networks and genomic, gastrointestinal, immune and gut-microbiome-related parameters. We will incorporate this new information, as well as the reported extensive literature on various peripheral mechanisms, into a systemsbased disease model of IBS, and discuss the implications of such a model for improved understanding of the disorder, and for the development of more-effective treatment approaches in the future.
Introduction
IBS is the most common functional gastrointestinal dis order, occurring in up to 15% of the population world wide. 1 Even though the syndrome is defined by chronically recurring abdominal pain and discomfort associated with altered bowel habits in the absence of organic disease, increased trait anxiety, as well as comorbid ity with psy chiatric and other chronic pain syndromes are common. 2 Despie an extensive body of reported information about peripheral [3] [4] [5] and central [6] [7] [8] [9] mechanisms involved in the pathophysiology of IBS symptoms, and the development of animal models with high face and construct validity (that is, the models have many features similar to and is based on a similar patho physiological concept as the human disease), 10 no compre hensive disease model has emerged that would guide the development of novel and effective therapies. This aspect is surprising in view of the comprehensive data as well as clinical experience demon strating the strong relationship between psycho social factors and IBS symptoms, 11 and in view of breakthroughs in the identi fication of several IBSrelated biological abnormalities at several levels: the gut epi thelium; 12 immune system; 4,5 neuroendocrine mechanisms; 13 brain structure and func tion; 7 stress response; 14 affective, 8, 15 cognitive 6, [16] [17] [18] and pain modulation 19, 20 abnormali ties; gene polymorphisms; 3 and the gut microbiome. 21, 22 Despite these insights, a comprehensive understanding of how these various factors interact, and particularly to what degree they are involved, in the generation of symp toms in IBS in general or in IBS subsets (as opposed to representing epiphenomena) has not emerged. The long history of IBS research 23 is full of examples of reported abnormalities (including excessive mucus production, alterations in sigmoid colon motility, slow wave abnor malities in smooth muscle, gut inflammation and others), which were reported in small sample cohorts and often not confirmed in vali dation sample cohorts. Typically, the majority of reported mean differences are small when compared with healthy individuals, often do not take into account sexrelated differences, might only be present in subsets of patients and correlations with clinical symptoms are weak. Thus, only a very small number of findings have translated into highly effective therapies. 24 These therapies include the serotonin (5HT) 5HT 3 receptor antagonist, alosetron, the 5HT 4 agonist, tegaserod, the guanylate cyclase agonist, linaclotide, and the chloride channel blocker lubiprostone (for chronic idiopathic consti pation). 25 Even though effective, the first two agents were restricted or withdrawn due to serious adverse effects, whereas the latter two are primarily targeted at treating the symptom of constipation. 25 The brain and gut show reciprocal interactions in health and disease. For example, altered brain outputs via the autonomic nervous system (ANS) and the hypothalamicpituitary-adrenal (HPA) axis have been shown to influ ence intestinal motility and secretion, 26 intestinal epithelial permeability, 3, 12, 27 immune function 28 and gut microbial composition. 21 In addition to these wellestablished influ ences of the brain on peripheral target cells, peripheral environmental gutdirected factors-in particular, dietary factors 29 and intestinal pathogens 30 -might have an equally important role on these same processes. Regardless of primary cause for the observed peripheral findings, several of them (in particular immune and microbiota related signalling) can feed back to the brain, setting up circular regulatory loops ( Figure 1 ).
Major barriers exist for progress towards a comprehen sive understanding of IBS pathophysiology, which incor porates such circular regulatory loops. Despite a wealth of information supporting all mechanisms listed already, controversy regarding the primary role of the brain versus peripheral factors has persisted in the field. The majority of research and drug development have focused on single, usually peripheral, targets in preclinical models (such as ion channels or specific receptors on individual neurons). Although such studies have provided major insights into mechanisms of visceral pain, 10 their relevance for IBS symptom generation in humans has not firmly been established. Integration of multiple clinical, psychosocial and biological (genetic, immune, neurobiological) find ings into a comprehensive disease model has yet to be achieved. For example, few studies aimed at psychosocial aspects of IBS have taken neurobiological concepts into account. The focus has been on descriptive, symptom based rather than biologybased disease definitions. In this Review, we will first describe novel insights into some key components of brain-gut-microbiome axis, starting with evolving concepts about alterations in defined structural and functional brain networks. We will discuss emerging evidence on how these brain network alterations are correlated with the immune system and the gut microbiota. We will then incorporate this infor mation, as well as the reported extensive literature on various peripheral mechanisms, into a systemsbased disease model of IBS. Rather than simply synthesizing the current knowledge about the disease, we will use this model to discuss the implications for better understanding of the disorder and for the development of moreeffective treatment approaches in the future.
The nervous system component
Several clinical observations support a major role of the brain in IBS symptoms: the brain is ultimately respon sible for generating the subjective experience of abdom inal pain, discomfort and anxiety; stressful life events in early life have a major role in vulnerability to develop IBS, and psycho social stressors in adulthood play crucial parts in the first onset, and perceived severity of symptoms; 32 centrally targeted pharmacological treatments and cog nitive behav ioural strategies are some of the mosteffective treatment strategies. 33 The role of the enteric nervous system (ENS) in the regulation and coordination of motor and secretory functions of the gastrointestinal tract, in sensory function and its interactions with the brain have been extensively reviewed. 34, 35 Consistent with the theme of this Review, the complexity of the inter actions between multiple gut based cell types (intrinsic and extrinsic sensory neurons, enteric glia, immune cells and inner vated entero endocrine cells) has been referred to as the 'gut connectome' . 36 The inter actions between the ENS and central nervous system (CNS), two key components of the brain-gut axis, are mediated by the sympathetic and parasympathetic branches of the ANS, 6 and by multiple sensory and endo crine pathways. 34 Although it is difficult to characterize alterations of the ENS or of ANSmediated brain-gut con nections in living humans directly, func tional, structural and metabolic brain imaging approaches have become a highly productive avenue to study brain-gut-microbiota interactions in health and disease. 8, 9, 37, 38 Although it has long been assumed that specific brain functions such as pain processing, emotion or cogni tion are attributable to the isolated operations of single brain regions, these processes are now viewed as result ing from the dynamic interactions of distributed brain areas operating in largescale networks (Figure 2 using neuro anatomical and neurophysiological studies in animals, 10 as well as different brain imaging tech niques and analy ses in humans. [39] [40] [41] [42] [43] [44] [45] [46] In humans, several types of networks have been reported: functional brain networks based on evoked responses 37 or intrinsic con nectivity of the brain during rest; [39] [40] [41] 44, 45 structural net works based on grey matter parameters 47 and white matter properties; and anatomical networks based on white matter connecti vity. 48 57, 62 IBSrelated alterations in these networks have provided plausible neurobiological substrates for several information pro cessing abnormalities reported in patients with IBS, such as biased threat appraisal and expectancy of outcomes (for example, salience network), autonomic hyperarousal (emotional arousal and central autonomic networks), and symptomfocused attention (central executive network). 63 In the next section, we will discuss IBSrelated changes that have been identified in these taskrelated networks. The individual networks are depicted in Figure 2 , and their basic properties are described in Table 1 .
Emotional arousal network
This network acts as an important link between stimulus appraisal (salience network) and ANS output (generated in the central autonomic network) to peripheral targets (gastrointestinal tract, gut microbes, immune system), thereby having an important role in determining the magnitude and duration of autonomic modulation of various gut functions. A reduction in the inhibitory feed back loop within the arousal network has been demon strated in patients with IBS compared with healthy individuals, 51, 64, 65 and in healthy individuals as controls after decreasing central serotonin levels by acute tryp to phan depletion. 66 Several studies published during the past decade support an increased responsiveness of emo tional arousal circuits in relation to both expected and to delivered visceral stimuli, particularly in women. [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] A metaanalyses of functional MRI studies published between 2000 and 2010 demonstrated that during con trolled rectal distension, patients with IBS show more consistent activation in regions associated with emo tional arousal than healthy individuals. 53 Emotional arousal circuit reactivity is associated with 5HTrelated gene polymorphisms. 77 IBSrelated functional alterations are accompanied by structural brain alterations in key regions of this network. Figure 2 | Brain networks contributing to IBS symptoms. Depicted are task-related brain networks that have been described in the literature and for which structural and functional alterations have been reported in patients wiht IBS. The box in the centre describes the clinical symptoms related to the network inputs. Outputs most relevant for IBS pathophysiology occur in the form of descending pain modulation and autonomic nervous system activity. Abbreviations: Amyg, amygdala; aINS, anterior insula; aMCC, anterior midcingulate cortex; BG, basal ganglia; dlPFC, dorsolateral prefrontal cortex; Hipp, hippocampus; Hypo, hypothalamus; LCC, locus coeruleus complex; M1, primary motor cortex; M2, supplementary motor cortex; mPFC, medial prefrontal cortex; NTS, solitary nucleus; OFC, orbitofrontal cortex; PAG, periaqueductal grey; pgACC, pregenual anterior cingulate cortex; pINS, posteria insula; PPC, posterior parietal cortex; sgACC, subgenual anterior cingulate cortex; Thal, thalamus; vlPFC, ventrolateral prefrontal cortex.
Central autonomic network
An extensive body of knowledge derived from rodent studies 26, [79] [80] [81] [82] supports an upregulation of brain circuits in response to chronic stress, in particular the input from the locus coeruleus complex to the amyg dala and the hypothalamus. Information from human brain imaging studies has been more limited due to the technical diffi culties in studying key regions of this network, such as the hypothalamus, locus coeruleus complex and sub nuclei of the amygdala, primarily due to limited spatial resolution. However, pharmaco logical brain imaging studies have implicated alterations in the corticotropinreleasing factor (also known as cortico liberin)-corticotropinreleasing receptor 1 64, 83 and norepinephrine-α adrenergic receptor signalling system in this network. 84 
Sensorimotor network
As with other chronic pain disorders, [85] [86] [87] [88] evidence indi cates that IBS might be associated with alterations in brain networks concerned with the central processing and modulation of viscerosensory and somato sensory infor mation. For example, compared with healthy individuals, patients with IBS showed increased low frequency power of spontaneous brain oscillations (suggesting increased Comprised of brain regions whose activity is greater during rest than goal-directed task performance 181 Associated with self-related processing, including monitoring internal thoughts and future planning 179, 182, 183 Emotional arousal network Amygdala, its positive connections with the locus coeruleus complex and inhibitory feedback projections to the amygdala from prefrontal and anterior cingulate subregions, and from the hippocampus Activated by perceived or real perturbation of the organism's homeostasis
Generates rapid feedback inhibition of amygdala, [184] [185] [186] thereby limiting the magnitude and duration of network activity and related activity in the central autonomic network
Central autonomic network
Control centres in the pontine-medulla (including PAG and hypothalamus), the central nucleus of the amygdala, and several cortical regions (including the anterior INS, ACC, prefrontal and motor regions) 187, 188 Regions related to SNS control overlap with the executiveprocessing and salience-processing networks (including the ventral anterior INS), whereas regions related to parasympathetic control are more associated with the default mode network 154 Provides central control and modulation of the ANS Involved in regulating respiratory, cardiovascular, endocrine and digestive system activity during cognitive, affective and motor tasks and sensation
Sensorimotor network
Core cortical regions are primary somatosensory cortex (S1, post central gyrus), primary motor cortex (M1; precentral gyrus), secondary somatosensory cortex (S2) and supplemental motor area 189 Close connections exist between the posterior INS (primary interoceptive cortex) and S1
Sensorimotor network connectivity to the thalamus, which relays peripheral sensory information to the cortex, 190 is established by 2 years of age 191 Receives sensory input from the periphery and is important for awareness of body sensations and generation of appropriate motor responses Primary and secondary motor cortex, through their projections to the central autonomic network, might have a modulatory role in the sympathetic control of visceral function 192 
Central executive network
Lateral prefrontal cortices and posterior parietal cortex 193 Activated during tasks involving executive functions such as attention, working memory, planning and response selection Often coactivated with regions of the salience network, 39 as the brain attempts to focus its limited processing capacity to only salient information via attention, working memory, planning and response selection 193 Salience network Dorsal ACC and anterior INS Core regions have strong connections to medial prefrontal and temporal regions, and subcortical regions including the amygdala, PAG and basal ganglia [194] [195] [196] Dorsal portions of the anterior INS receives prefrontal input, whilst ventral portions are closely linked with the amygdala and emotional arousal system Anterior INS can be considered the main hub in the brain, switching from default mode network to activity-related networks, and coordinating and adjusting bodily and behavioural responses to environmental changes Responds to subjective salience of any interoceptive and exteroceptive stimulus reaching the brain, or to the expectation of such stimuli, and coordinates appropriate attentional, behavioural, affective and visceral responses to such stimuli 39, 197 Responds with the most appropriate responses to biologically and cognitively relevant stimuli based on maintaining homeostasis 193, 194 regardless of whether the subject is awake, engaged in a particular task, or asleep (achieved through close salience network connections with the other networks) Abbreviations: ACC, anterior cingulate cortex; ANS, autonomic nervous system; INS, insula; PAG, periaqueductal grey; SNS, sympathetic nervous system. REVIEWS neural activity) in regions belonging to the sensorimotor network. 59 These functional changes seem to be accom panied by structural changes in white and grey matter. For example, patients with IBS had widespread micro structural white matter abnormalities in sensory process ing and/or modulation regions. 89 Female patients with IBS have cortical thickness increases in sensorimotor areas that correlated with clinical measures of symptom sever ity compared with healthy individuals. 90 Such grey matter increases in patients with IBS were also seen in the poster ior insula (INS), the primary viscerosensory cortex, and these changes were correlated with IBS symptom dura tion. 91 Volumetric grey matter analyses in a large sample of female patients with IBS revealed increases in the primary somatosensory cortex. 78 Furthermore, examining struc tural networks in IBS indicated that two key regions of the network (cingulate gyrus and thalamus) were found to be network hubs, indicating that these regions are more critical for information flow in IBS compared with health. 78 When viewed together, current evidence supports the hypothesis that patients with chronically recurring vis ceral pain and/or discomfort have functional as well as neuroplastic and microstructural alterations within the brain, particularly in regions associated with the process ing, integration and modulation of sensory information. The mechanism(s) underlying these alterations include chronically increased viscerosensory information flow from the gut, or from dorsal horn neurons sensitized by descending pain facilitation (see Figure 3 ).
Evidence indicates that patients with IBS might have func tional impairments in cognitive processes associated with the central executive network. 16, 17 Preliminary evidence based on administration of the Attentional Network Test 92 suggests that patients with IBS have greater behavioural efficiency during the alerting and orienting function of attention than healthy individuals. In comparison with healthy individuals, this greater efficiency was associ ated with greater activation of anterior midcingulate and insular cortices, confirming the previously reported close interactions between the central executive network and the salience network. 39 Converging evidence also sug gests that increased attention to gastrointestinal symp toms and contexts have an important role in the increased percep tual sensitivity to visceral stimuli characteristic of IBS. 26 Patients with IBS show deficient activation of inhibitory cortical regions involved in downregulation of pain and emotion as well as attention during expecta tion and experi ence of aversive gastrointestinal stimuli. 53 Selective recall of negative and gastrointestinal sensa tion words, as well as selective attention to threatrelated stimuli, has been demonstrated in patients with IBS. [93] [94] [95] [96] Furthermore, a reduction in the effective connectivity of the central executive network circuitry (including par ietal, dorsal lateral prefrontal cortex) during repeated exposure to the antici pation and experience of a threat ening gastro intestinal stimulus (repeated exposure to balloon inflations) was associated with a reduction in IBS hypersensitivity. 97 Data from a sample of Japanese patients with IBS, compared with healthy controls, indicated that alterations in error feedback mechanisms were associated with decreased dorsolateral prefrontal cortex activity. 16 A strong negative correlation between the cortical thick ness and grey matter density of the dorsolateral prefron tal cortex and pain catastrophizing has been reported. 98, 99 Evidence from the University of California, Los Angeles research group indicates prepulse inhibition, a process by which an organism can filter the flow of information from its internal and external environments, is altered in IBS compared with health. 60 Together, these data suggest that patients with IBS have specific abnormalities in attentional processes that have a role in the increased perception of visceral stimuli and in IBS symptom severity.
Salience network
Studies performed during the past decade on brain responses to delivered and expected rectal distension have consistently reported increased engagement of the core regions of the salience network, the anterior INS and anterior midcingulate cortex in patients with IBS, 7, 37 which initially but incorrectly were referred to as the "pain matrix". In addition, a close relationship between increased affect, central emotional arousal processes and enhanced visceral stimulus perception has been reported in patients with IBS. 65, 100, 101 Three recent reports published between 2013 and 2015 in female patients with IBS have identified diseaserelated alterations in anterior INS activ ity and connectivity in the resting state 58, 59 and during an ambiguous abdominal pain threat, 102 confirming a key role of salience network alterations in IBS. Reported altera tions in the response and connectivity within the salience network are consistent with the prediction error character istic of patients with IBS about the likelihood and severity of future gastrointestinal symptoms (catastrophizing). 15 Integration of brain networks An extensive body of literature supports the model of the central role of aberrant salience computation underlying key clinical IBS symptoms (depicted in Figure 3 ). Well established biological and behavioural consequences exist with such a biased appraisal: the engagement of altered ANS outputs to targets in the gastrointestinal tract (inclu ding ENS activity, gut permeability, gastro intestinal motility and secretion, 3 gut microbial composition and metabolites), 21, 22 and to extraintestinal targets (inclu ding the immune system); 103 shifting of the balance of endoge nous pain modulation systems towards increased descend ing pain facilitation; 20 increased engagement of the central executive network resulting in selective attention to gastro intestinal symptoms; and development of prediction errors about likelihood and severity of symptoms (socalled catastrophizing). 104, 105 The model also provides a plausible bio logical basis for the effectiveness of different behav ioural interventions such as cognitive behavioural therapy (normalizing salience, executive control and emotional arousal networks), selfrelaxation techniques (normalizing emotional arousal and central autonomic networks) and mindfulnessbased stress reduction (normalizing salience and executive control networks). 63 
Genetics and epigenetics
As with many other chronic diseases that involve the brain, IBS probably has a strong developmental compo nent, which starts with the interactions of genetic and epi genetic factors early in life, including the prenatal period. In addition to the reported associations of gene variations with various peripheral mechanisms, 106 imaging genetics studies performed in large samples of wellphenotyped individuals with and without IBS have identified inter actions between early environmental factors, 107 candi date gene polymorphisms and brain networks related to emo tional arousal and/or central autonomic control, salience and somatosensory integration. The reported genes were related to the regulation of the HPA axis: corticotropin releasing hormone receptor 1 (CRHR1, single nucleo tide polymorphisms [SNPs] rs7209436, rs110402 and rs242924); glucocorticoid receptor gene (NR3C1, SNPs rs2963155 and rs33389); 108, 109 female sex hormones (progesterone receptor or PGR, SNPs rs1042838 and rs10895068); 109 5HT signalling system (HTR3A c.-42C>T SNP rs1062613), 77 inflammationrelated genes (IL1B, SNP rs16944); 108 and catecholaminergic signalling (ADRA1D, SNP rs1556832; ADRA2B, SNP rs1042717; COMT, SNP rs174697). 110 As discussed in the next section, these inter actions are markedly influenced by epigenetic factors 111, 112 (such as a history of early adverse life events [EALs] ) and by the sex of the study participant ( Figure 4) .
As with other polygenic disorders, it has become clear that no single gene variation is sufficient to explain the full clinical phenotype in IBS. However, interactions between multiple genes, early life experiences and sex probably make a small contribution to the overall vari ance of the peripheral and central endophenotypes. 107 Validation studies in larger samples are required to confirm such contributions.
The external environment component
Various influences originating in the external environ ment (Figure 1) can markedly affect the development, chronicity and severity of IBS. Although some of these influences are mediated by the brain (psychosocial stress, social support, societal responses to symptoms) others are mediated by the gastrointestinal tract, includ ing the gut microbiota, diet, gastrointestinal infections and medications.
Brain-mediated influences
Clinical literature on the role of psychosocial factors in the development, symptom persistence and symptom flares in IBS is extensive. 18 In addition to the welldocumented Nature Reviews | Gastroenterology & Hepatology role of stressful life events in adults in preceding or exacerbating IBS symptoms, 32 a history of EALs is associ ated with an increased vulnerability to IBS, 113 disorders of mood and affect, 114, 115 as well as to a wide range of other chronic diseases. 116 In contrast to the earlier emphasis on the role of a sexual abuse history, it is now clear that a variety of factors that disturb the quality of the inter actions between the primary care giver and the child during the first 18 years of life (including serious illness of the mother, marital discord, divorce, verbal and emo tional abuse) can have equally detrimental effect on adult disease vulnerability. 116 Evidence from brain imaging studies have identified structural and functional brain alterations associated with selfreports of EALs. Structural alterations in regions of the emotional arousal circuitry 78 and in regions associ ated with modulating somatosensory and viscerosensory processes 90 were correlated with such reports. Alterations in the activity in the brainstem and amygdala in response to noradrenergic stimulation has been associated with increasing levels of EALs, consistent with an upregu lation of central autonomic circuits in IBS. 117 Selfreports of EALs were also found to be correlated with brain acti vity in net works involved in determining the salience of somatic, visceral or environmental stimuli in IBS. 57 These results suggest that the experience of adversity early in life can lead to altered resting state activity in the salience and in the central executive network of adults with IBS, possibly leading to permanent alterations in salience computation of viscerosensory signals by the brain. The observed alterations in the functional connectivity of the emotional arousal 51 and salience networks 57 found in IBS might be driven by altered central noradrenergic modulation. 50, 64 Similar changes have also been observed in animals exposed to early life stressors, 118 and have been linked to increased sympathetic nervous system responses. 119 EALs are also associated with altered signalling within the HPA axis. 120, 121 A study published in 2009 demonstrated that selfreport of EALs was associated with exaggerated HPA axis responses to an aversive visceral stimulus, an effect that was more pronounced in male participants. 113 Considerable preclinical and clinical evidence supports the concept that gene expression can be influenced by EALs through epigenetic mechanisms, including DNA methylation, and that these effects can persist throughout adult life. 115, 122, 123 As depicted in Figure 4 , interactions of EALs, sex and vulnerability gene polymorphisms might increase the risk of developing IBS by shaping the connec tivity of relevant brain networks (see previous section). Even though the prevalence, clinical importance and underlying molecular mechanisms of EALs have been studied in great detail, there are other factors through which the external environment can influence brain func tion. These include, but are not limited to, the beneficial role of a strong social support system, which can miti gate the negative effects of EALs, and societal responses to patients' symptom reporting, which can drive a vicious cycle of symptom amplification. Gastrointestinal-tract-mediated influences Factors arising from the external environment have been implicated in the pathophysiology of IBS and in the modu lation of IBS symptoms. These factors have been reviewed elsewhere and so will not be discussed in detail here: dietary factors; [125] [126] [127] [128] pathogenic micro organisms; 129, 130 and antibiotic treatment. 131, 132 It remains to be determined if patients with IBS have abnormal mucosal responses to any of these factors, if symptoms reported in relation to these factors are mediated by alter ations in the gut micro biota (see section on gut micro biota), or if it is simply the sensitivity of visceral perception that determines if some body develops symptoms or can tolerate the same factors without any symptoms.
The immune system component IBS is not an inflammatory disease, but a growing body of research suggests that dysregulation in immune function might nevertheless contribute to its aetiology or symp toms. 4, 5, 133 Mixed data exist on whether plasma or intestinal mucosal cytokine levels are associated with IBS. 5 However, other research has linked IBS to an increased reactivity of blood monocytes and increased numbers of mucosal mast cells. [134] [135] [136] [137] [138] [139] Some studies also indicate that peripheral blood mononuclear cells (PBMCs) from patients with IBS show abnormal release of proinflammatory cytokines such as IL6, IL1b and TNF. 5 These observations in IBS are consistent with the broader role of the nervous system in regulating immune cell development and gene expression via neuro endocrine signals from the brain (for example, corti sol from the HPA) and activation of sympathetic nerve fibres in the one marrow and other lymphoid organs (for example, via the sympathetic neuroeffector mol ecule norepin ephrine). 103, [140] [141] [142] These regulatory interac tions enable the CNS to integrate information regarding the general internal state of the body with information regarding real and perceived environmental threats (as detected by the salience network) and historical or devel opmental influences (for example, a history of EALs 143 ). As one example of these regulatory effects, studies have found that stressful life circumstances are associated with the activation of a socalled conserved transcrip tional response to adversity (CTRA) in PBMCs that is characterized by increased expression of proinflamma tory genes and decreased expression of genes involved in innate anti viral responses (for example, type I inter ferons) and IgG antibody production. 103, 140, 144, 145 CTRA gene expression can also be experimentally invoked by social stress in animal models 145, 146 and is mediated in part by sym pathetic nervous system (SNS)induced increases in bone marrow haematopoietic production of imma ture and immuno logically primed monocytes (CD16 -in humans, Ly6c hi in mice). 146 These primed monocytes can also be reciprocally recruited into the CNS by exposure of mice to social threat and aggression. 147 The integration of these observations suggests a new hypothesis regard ing the immune system's role in the pathogenesis of IBS: high levels of SNS acti vity during early developmental periods (stemming from either genetic or environmental triggers such as EALs) might lead to increased production of immature primed monocytes that both traffic into the gut to alter local function and ENS plasticity, and traffic into the brain to affect CNS plasticity (including struc tures involved in salience processing and autonomic regulation). The result can be viewed as a physiological Hebbian association between gut biology and brain func tion, resulting in a selfperpetuating feedback system in which a sensitized gut generates ongoing adverse sensory experi ences (symptom flares), to which a neurally sen sitized brain responds with both greater aversion and increased sympathetic outflow, resulting in upregulated monocyte production that further promotes neural alterations in both the gut and the brain.
Several areas of empirical evidence are consistent with this systemslevel brain-immune-gut hypothesis, inclu ding: brain regulation of primed monocyte production via the SNS; 148 stressinduced migration of primed mono cytes to the brain; 147 inflammationinduced neuro plastic changes in the brain 149 (for example, altering affective behaviour 147 ); reinstatement of previous stress effect on brain and behaviour by subsequent exposure to mild stress weeks after the initial sensitization; 148 and the observa tion that patients with IBS (and animal models of EAL) show increased stress responsiveness (for example, SNS activity 150 ) and increased responsiveness of brain cir cuits related to salience detection, emotional arousal and autonomic response. 151, 152 Additional evidence was examined from a pilot study in which the PBMC gene expression profiles from 20 patients with IBS (12 female) and 20 healthy indi viduals (nine female). 153 Analyses identified 280 gene transcripts showing >10% differential expression across groups (134 genes upregulated in PBMC from IBS, and 146 downregulated). Promoterbased bioinformatics analysis implicated several transcription control path ways in structuring the observed transcriptome differ ences, including increased activity of CREB transcription factors (which mediate βadrenergic signalling from the SNS), growth control pathways (for example, the MAPK responsive transcription factor ELK1), oxidative stress response pathways (NRF2), and pathways involved in growth factor and cytokine signalling (STAT). However, PBMCs derived from patients with IBS did not differ from those from healthy individuals in the activity of proinflammatory transcription factors such as NFκB or AP1. Transcript origin analyses 154 indicated that IBS upregulated genes derived predominately from mono cytes and dendritic cells. Additional transcriptome repre sentation analyses suggest that these effects stemmed at least in part from upregulation of immature (CD16 -) monocytes within the PBMC pool of patients with IBS. These results are all consistent with a pattern of increased myeloid lineage cell development in patients with IBS, which might stem from tonically increased SNS signalling to bone marrow myelopoietic processes. 146 Consistent with the hypothesis that CNS processes might mediate relationships between IBS and periph eral myelopoiesis, differential signalling by the myeloid lineage transcription factor MZF1 was positively associated with the morphometry of brain regions of the emotional arousal network 155 (previously reported to be altered in IBS 78, 90, 156 ). These associations included bilat eral amygdala, hippocampal and anterior INS volumes, and bilateral anterior INS cortical thickness (all P <0.05). Moreover, these associations were reasonably specific in that other brain regions showed either no associ ation, or negative associations (for example, bilateral cerebellar volumes).
In conjunction with the published data reviewed here, these preliminary results suggest that key regions of the emotional arousal and/or central autonomic net works, which differ structurally between IBS and healthy indivi duals are also related to differential gene regula tion in the peripheral immune system. We hypothesize that these chronic influences of the brain on peripheral monocytes ('top down') might have a role in the reported PBMC abnormalities in IBS, whereas primed monocytes migrating to the brain might have a role in the ('bottom up') generation of visceral hypersensitivity, anxiety and neuroplasticity during recurrent stressors.
The gut microbiota component
Evidence from rodent studies supporting bidirectional interactions between the gut microbiota and the nervous system (both CNS and ENS) has been summarized in numerous review articles. [157] [158] [159] [160] Even though various sig nalling mechanisms underlying such interactions have been proposed, detailed mechanistic studies regarding the relative contributions of neural, hormonal, metabolite or immunemediated factors are required to draw definitive conclusions. Evidence from human studies using different endpoints (symptoms, brain imaging studies) confirming the rodent findings, or identifying a definitive pattern of dysbiosis in patients with IBS are limited. 158 Conflicting evidence exists regarding alterations to the organization and function of the gut micro biota in patients with chronic abdominal pain and in adult and paediatric patients with IBS. 21, 22 Several studies examining faecal samples from patients with IBS reported decreased proportions of the genera Bifidobacterium and Lactobacillus, and increased ratios of Firmicutes:Bacteroidetes at the phylum level, even though a causal role of these microbial changes in clini cal symptoms has not been established. On the other hand, one might speculate that some of these changes might be related to alterations in regional gut transit and secretion secondary to altered ANS output. A study in a cohort of wellphenotyped patients with IBS high lights the complexities of brain-gut-microbiota altera tions in IBS. 31 IBS subgroups were identified based on hierarchical clustering of operational taxonomic unit information from 16S ribosomal RNA analyses. 31 Two IBS clusters were clearly separated from each other, from a 'normallike' IBS sample and from the healthy control sample. Although the normallike IBS sample showed normal diversity and normal Firmicutes:Bacteroidetes ratio (as in, similar to the pattern in the healthy control sample), another cluster showed diminished, and a third cluster showed increased diversity. Both of these clusters showed increased Firmicutes:Bacteroidetes ratios. Only the normallike IBS group showed a markedly elevated rate of depression symptoms (40%). In addition, pro longed colonic transit times, common in patients with depression correlated with the prevalence of 17 taxa. 31 In a randomized, placebocontrolled study of healthy men and women, psychological distress and anxiety improved after taking a Lactobacillus-containing and Bifidobacteriumcontaining probiotic compared to those taking a matched control product, although another study using a different Lactobacillius probiotic failed to confirm these findings. 161, 162 Findings from brain imaging studies in healthy indi viduals and patients with IBS has provided some evi dence supporting reported rodent gut microbiota-brain interactions. One study has shown that chronic ingestion of a probiotic consortium (Bifididobacterium animalis ssp. lactis, Lactococcus lactis spp. lactis, Lactobacillus delbrueckii spp. bulgaricus and Streptococcus thermophilus) for 4 weeks altered functional brain responses to an emotional face recognition task in healthy women. 52 Compared with two control groups (one group received a nonfermented milk product and the other no treatment), the women who had ingested the probiotic had a reduced response to the task across a wide network of brain regions that included sensory and emotional regions. Although no treatmentrelated changes in selfreport of symptoms of anxiety or depression were seen, the find ings suggest a basic change in responsiveness to negative emotional stimuli in the environment. No organi zational changes in the gut microbiota were observed in this and a previous nonimaging study using the same interven tion. 163 The effects of the probiotic intervention on brain responsiveness were probably mediated by a change in microbialderived metabolites; this hypothesis will have to be confirmed in future studies. Preliminary evidence investigating correlations between gut micro bial metabo lites and brain structure in healthy indivi duals and patients with IBS demonstrated statistically significant correlations between several metabolites and structural aspects of several brain regions. 153 
An integrated model
Hypothesis On the evidence reviewed here, the following model is proposed that lends itself to experimental evaluation. The hypersensitive brain, and presumably ENS, shows increased responses to a variety of viscero sensory and exterosensory stimuli, which by themselves might not be consciously perceived in healthy individuals or in patients with inflammatory bowel disorders in whom intact descending inhibitory bulbospinal influences reduce dorsal horn excitability. 20, 164 This hyperresponsiveness might be a primary genetic or epigenetic alteration in certain brain networks (autonomic, emotional arousal or salience), or might be secondary to chronic experience of increased sensory input from the gut. Such increased viscerosensory signalling could originate from any of the elements of the gut connectome. Altered brain networks generate altered signals, which are transmitted to the periphery through the ANS, HPA axis and descending modulation to the dorsal horn. The chronically increased ANS output, results in an extensive remodelling of various peripheral cells in the immune system, ENS, gut epithe lium (permeability), and in the composition and function of the gut microbiota, all contributing to sensi tization of visceral afferent pathways, and increased viscero sensory feedback to the brain, reinforcing the circular regulatory loops. Memory formations at the level of the immune system, the nervous system and the gut microbiota early in life are likely to contribute to the chronicity of symptoms.
Systems biology view
The evidence reviewed above strongly suggests that IBS is a systems disease ( Figure 5 ), involving not only complex individual systems-nervous, immune, digestive, micro biota and the environment-but also their complex, non linear, reciprocal interactions. Thus, we propose a systems biological view of IBS pathophysiology, an approach taken in other areas of biology and disease 165, 166 involving a large number of functionally diverse, interacting components, each of which contributes only a small fraction to the vari ance of the symptoms. These components interact highly selectively at multiple scales and typically in a nonlinear fashion to produce coherent behaviours and outcomes. 167 Applied on a macroscopic level, we propose this model to characterize the interactions of the nervous system, immune system, the gut environment (motility and secretion), the gut microbiota and the external environ ment (Figures 1 and 5) . The nonlinearity of the model is reflected by the complexity of these macroscopic com ponents and their macroscopic interactions, which form circular regulatory loops. Applied to the microscopic level, the model proposes the interactions between highly diverse cells types making up the various macroscopic components ( Figure 5) .
Given the complexity of the expanded gut-microbiotabrain-environment axis, and with the rapid advance of ana lytical tools, in particular of 'omics' technologies-in the case of IBS studies, primarily geno mics, transcripto mics, proteomics, metabo lomics, brain connectomics and their integration into, for instance, gene and protein networks-we believe that systems bio logical approaches are essential to fully understand symptom generation and to identify novel treatment approaches in the future.
The multiorgan, systemic view of IBS leads to the pre diction that disease models focusing on individual cellu lar components at the macroscopic level (brain, immune system, gut, microbiota, environment) will have limited validity. Furthermore, this view predicts that therapies targeted at single organs (for example, brain, immune system, gut), single mechanisms (for example, secretion, motility, gut microbiota, pain, diet), or single molecular targets (such as ion channels or receptors) are not likely to be successful in treating the entire syndrome, as evidenced by the limited success in drug development for IBS to date, reflected in rather small effect sizes on overall changes in IBS symptoms. This problem is compounded by the fact that different subsets of patients can be charac terized by different patterns of interactions between the components of the overall system, resulting in differential responses to a particular therapy.
Indeed, each isolated mechanism proposed over the past 30 years only explains a small fraction of the vari ance of the clinical phenotype 26 and no isolated therapies have had better effectiveness than ~10% over placebo. 168 In addition, the systems view predicts that a single agent targeting multi ple components of the system (tricyclic anti depressants, 5HT 3 antagonists), or combined thera pies, aimed at simultaneously targeting multiple organs and mechanisms (combination of laxatives, anti diarrhoeal agents, probiotics and centrally acting drugs) are likely to be more effective in the clinic, than individual treatments by themselves. Although no controlled studies have been conducted yet and are needed, in our opinion, this sug gested integrated approach is in part supported by current clinical practices and the consensus of most physicians.
Although still in their infancy, integrated multiomic approaches could be essential in the future to better under stand the disease spectrum for IBS at the system level and the underlying mechanisms. Ideally, one would like to combine highthroughput microscopy and brain imaging to obtain brain connectome variables, and sequencing and mass spectrometry methods to obtain complete measurements of genomic, epi genomic, transcriptomic, proteomic and metabolomic variables simultaneously in multiple organs and tissues (in particular in gut and brain), including the micro biota. Data derived from these -omics approaches can be integratively analysed in com bination with other sources of information ranging from public databases to the liter ature to identify, for instance, targetable hubs. This integrated -omics approach faces major obstacles stemming from the obvious difficulties of performing some of these analyses in human patients (for example, nervous system tissue). However, impor tant steps can be taken in this direction both using rodent models 10, 81, 169, 170 and by performing partial measurements in humans.
Some of these analyses should be performed at multiple time points along the circadian cycle. Circadian rhythms are found at the molecular level in all tissues, both centrally and peripherally, and have a fundamental role in coordin ating the physiology and homeo stasis of the organism. Indeed integrative system biology analyses 171 have revealed that about 10% of all transcripts and metabo lites oscillate in a circadian manner in any tissue, 172 with little overlap across different tissues beyond the core molecular clock comprising a transcriptional-translational negative feed back loop coordinated by a dozen genes. 173 Furthermore, the list of oscillating molecular species in a given tissue is altered by genetic, epigenetic and environmental pertur bations and thus provides a characteristic physiological signature of a tissue and its health state. [174] [175] [176] Furthermore, complex reciprocal interactions exist between the mol ecular rhythms found in different brain regions and in other organs. Thus, in short, it is reasonable to predict that IBS should result in perturbed lists of transcripts and metabolites that oscillate in a circadian manner both centrally in specific brain areas as well as peripherally, for instance in the gut.
Conclusions
Clearly, none of the growing list of individual abnormali ties identified in patients with IBS by itself can account for the variance of the clinical phenotype. For the same reason, such individual abnormalities are unlikely to rep resent reliable biomarkers and are not likely to represent suitable targets for the development of highly effective treatments. Rather, as depicted schematically in Figures 1  and 5 , the clinical phenotype emerges from the inter actions of multiple systems in the periphery (gut con nectome, microbiome, genome and epigenome) and in the brain (connectome) interacting with each other in bidirectional ways. Most consistent with a systems view is the concept that central and peripheral abnor malities form circular loops that reinforce each other. In the absence of comprehensive phenotyping studies in patients with IBS performed longitudinally with or without therapeutic interventions, and without targeted mechanistic animal studies, it remains unclear which of these reported abnormalities are primary and which are secondary. On the basis of this assessment, we suggest that in the future, highthroughput -omics measurement across both tissues and time, combined with comprehen sive characterization of clinical, behavioural and brain endophenotypes, should enable more accurate differen tial analyses, uncover complex systemlevel interactions and, ultimately, help develop more efficient, multi pronged therapies. 177 Such a system biological approach might not only hold promise when applied to IBS and related functional gastrointestinal disorders, but also for inflammatory diseases of the gut, such as IBD and coeliac disease. 178 
